Pollen Streel deal is latest example of buy-and-build continuation funds

Are you a GP lacking follow-on capital for an add-on? A continuation fund could be right for you – so long as it's done right.

SECONDARIES INVESTOR

Register to unlock this content

• Daily global secondaries market news and intelligence
• Curated insights to keep you ahead of GP-led and LP-led secondaries
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

CommentaryEditor's ViewWestern EuropeGP-Leds